Molecular Inflammation Board at the Center for Personalized Medicine (MEB@ZPM)

University Hospital Tuebingen

Status: Enrolling

Conditions: Psoriasis Arthritis; Spondylarthropathies; Psoriasis (PsO); Inflammatory Bowel Disease (Crohn's Disease and Ulcerative Colitis)

Treatments: Biological: Biologic Agent

Study type: Observational

Funder types: Other

Identifiers

NCT07132333

482/2022BO1

Details and patient eligibility

About

Molecular Inflammation Board at the Center for Personalized Medicine

Full description

Molecular Inflammation Board at the Center for Personalized Medicine

The study objectives are:

To ensure a prospective documentation of all patients who are referred to the Molecular Inflammation Board in routine clinical care To prospectively ensure the documentation of MEB patients with an emphasis to clinical outcome parameters and further response assessments (e.g. peripheral immunmonitoring, imaging parameters) To prospectively assess patient-reported outcome of MEB patients To evaluate compliance to MEB suggestions in routine clinical care

Enrollment: 3,000 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Chronic inflammatory disorder (PsO, PsA, SpA, IBD)
• Given informed consent
• 18 years of age

Exclusion criteria

• No capacity to consent